Peripheral blood lymphocytes from normal human volunteers or from Down syndrome patients were pre-treated with sodium butyrate (a compound which is known to induce structural modifications in the chromatin through hyperacetylation of nucleosomal core histones) and exposed to X-irradiation or treated with bleomycin in vitro in the G o and/or G x stage(s) of the cell cycle. The frequencies of chromosomal aberrations in the first mitosis after treatment were scored.
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. used in these experiments. The enhancement in the 1. Introduction c . c ,. . . , , , , , frequencies of radiation-induced chromosomal aberTreatment of mammalian cells with sodium butyrate rations was therefore tentatively interpreted as a (hereafter to be referred to as butyrate) has been consequence of butyrate-induced conformational known to induce structural modifications in chromatin change in the chromatin of G o lymphocytes; however, through hyperacetylation of nucleosomal core his-the question of whether at biologically meaningful tones (Riggs et al. 1977; D'Anna et al. 1980; Bode doses, such as those used in cytogenetic experiments, et al. 1983; Pani et al. 1984) . Smerdon et al. (1982) and alteration in DNA repair capacity might also play a Ramanathan & Smerdon (1989) showed that butyrate-role, could not be answered. treated human fibroblasts exhibited a marked increase
In this paper, we present the results of three sets of in DNA-repair synthesis at early times after UV-experiments. The first of these was designed to inquire irradiation and that this increase was primarily whether X-irradiation of butyrate pre-treated lymphoassociated with nucleosome core regions in hyper-cytes at the G l stage of the cell cycle would elicit a acetylated chromatin.
response similar to that observed with G o lymphocytes. In our earlier study (Sankaranarayanan et al. 1985) , The rationale for this derives from the findings that (i) we found that butyrate pre-treatment of unstimulated chromatin modifications normally occur when cells (G o ) human peripheral blood lymphocytes prior to X-pass from the G o to G, stage of the cell cycle; (ii) G l irradiation (0-25-2 Gy) led to an increase in the lymphocytes have generally been found to be more frequencies of chromosomal aberrations as compared sensitive than G o cells to the induction of chromosomal to cells that received only X-irradiation; however, the aberrations (e.g. Wolff, 1972; Beek & Obe, 1977) and numbers of X-ray-induced DNA-strand breaks and (iii) actual measurements of histone acetylation in the extent of repair (as measured by the nucleoid different stages of the cell cycle in CHO cells (D'Anna sedimentation technique) were the same in butyrate-et al. 1977; Gurley et al. 1978) have shown that, treated and untreated cells at the dose level of 10 Gy normally, there is a substantial amount of histone acetylation in G r t Corresponding author.
The second set of experiments was aimed at examining whether the response of butyrate pretreated G o lymphocytes to the induction of chromosomal aberrations by bleomycin, a radiomimetic compound, would be similar to that after X-irradiation. The third set of experiments was conducted to explore whether one can discriminate the role of butyrate-mediated chromatin modification from that of possible enhancement of DNA (mis)repair in butyrate-treated cells, through the use of G o lymphocytes from Down syndrome patients. As is wellknown (e.g. Sasaki & Tonomura, 1969; Evans, 1972) , G o lymphocytes from Down syndrome individuals can be more sensitive (by a factor of about 1-5-2) to the induction of dicentric and ring aberrations by Xrays than are lymphocytes from normal individuals, and this has been interpreted as due to more rapid (mis)-repair of DNA damage leading to chromosomal aberrations (Preston, 1981) .
(b) The effects of butyrate pre-treatment on the frequencies of X-ray-induced chromosomal aberrations in G o and G r lymphocytes
In the G o experiments, cultures were first set up in medium without PHA, treated with butyrate (5 mM final cone.) for 24 h after which they were irradiated, washed and resuspended in fresh medium containing PHA. 5-bromodeoxyuridine (BrdU) was added to one culture of each treatment group to check on cell cycle progression. The cells were fixed at 48 or 50 h after PHA stimulation, preceded by a 2 h colcemid treatment. In the G t experiments, cultures were set up in PHA-containing medium; 1 h later, butyrate was added (5 mM final cone). After about 14-15 h, the cultures were X-irradiated, washed and resuspended in fresh PHA-containing medium. The remaining steps in the experimental protocol were the same as with G o cultures.
Material and Methods
Blood from healthy donors obtained from the Blood Bank of the Academic Hospital, Leiden or from volunteers in our laboratory, was used to set up whole blood cultures. For experiments using blood from Down syndrome patients, samples were obtained through the courtesy of Drs Timar Laszlo and A. Czeizel of the National Institute of Hygiene, Budapest, Hungary.
(a) Comparison of chromosomal radiosensitivities of G o and G x lymphocytes
Before embarking on experiments on the effects of butyrate, it was considered useful first to establish whether G x cells are more sensitive than G o cells to the X-ray induction of chromosomal aberrations. Therefore, in the first experiments, whole blood cultures were established each in 5 ml of PHA-containing Ham's F10 medium supplemented with 15% foetal calf serum. In the G o series, they were X-irradiated immediately and allowed to progress through the cell cycle; in the G t series, at about 14-15 h after PHA stimulation (this timing was based on the study of Beek & Obe, 1977) , the cultures were irradiated and allowed to continue their progression through the cell cycle. Appropriate concurrent controls were run. Colcemid was added for the last 2 h in culture and all fixations were done at 50 h after PHA stimulation. Fixation, slide preparations and staining (Giemsa) were according to standard methods. The slides were scored for dicentrics, rings, and acentric fragments as well as for chromatid-type aberrations (chromatidbreaks and exchanges). Chromatid and isochromatid gaps were also scored, but were not included in the calculations since these showed no systematic differences between the different treatment groups. Blood from two Down syndrome patients (DS1, a male born on 16-11-87 and DS2, a female born on 5-4-88) and two fixation times (46 and 48 h) were used, the protocols being the same as those described above. All X-irradiations were carried out at room temperature with an ENRAF machine operated at 150 kV, C mA, 1 mm Al filtration at a dose rate of about 120rad/min. Doses and dose-rates were monitored using a PTW dosimentor system. 
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Results and Discussion
(a) Comparison of the frequencies of chromosomal aberrations induced in lymphocytes after X-irradiation in G o and G r stages of the cell cycle
Data from these experiments are summarized in Table 1 . It should be recalled that the radiosensitivity of G t lymphocytes was assessed by X-irradiating the cultures at 14-15 h after PHA stimulation, at which time-period, Beek and Obe (1977) found the sensitivity differences between the G o and G t stages to be maximal. Inspection of Table 1 will reveal that G, lymphocytes are in fact more sensitive to the induction of dicentrics and rings (by a factor of between 1-5 and 2-2) and this is true of the lymphocytes of both the donors. These results are in good agreement with those of Wolff (1972) and of Beek & Obe (1977) ; for the induction of acentric fragments, G t cells appear to have a slightly more (13x; 1 Gy, both donors) or about an 1-5-fold higher sensitivity (2 Gy, both donors). The frequencies of chromatid breaks, in general, are higher in G t than in G o cells.
(b) Comparison of the effects of butyrate pretreatment on the frequencies of chromosomal aberrations induced by X-irradiation of G o and G 1 lymphocytes
The results are summarized in Tables 2 and 3.  Considering first Table 2 , it can be seen'that with lymphocytes from donor A, two dose levels (1 and 2 Gy) were employed whereas with donor B, only one dose of 1-5 Gy was used. As will be clear, in all the experiments (i) with no butyrate treatment, the frequencies of dicentrics and rings are higher (by factors in the range of 1-2 to 1-6) in G x than in G o cells and (ii) in both cell stages, butyrate pre-irradiation treatment leads to an enhancement of these frequencies and this enhancement is approximately of the same magnitude. The situation with respect to acentrics is similar (relative increase in butyrate pre-treated groups in the range of 1-3 to 2).
The variation in the frequencies of dicentrics and rings with radiation treatment alone, and in the magnitude of increase with butyrate pre-irradiation treatment noted with blood samples from the same donors (compare Tables 1 and 2 ) prompted us to examine whether there are radiosensitivity differences between blood samples from different donors and whether the relative increase (with butyrate preirradiation treatment) seen with G o cells provides an indication of the enhancement expected with G, cells from the same donor studied simultaneously. The results are given in Table 3 and provide support for the existence of inter-individual variations with respect to (i) the sensitivity of G o and G x cells to X-rayinduced chromosomal aberrations and for (ii) a parallelism in response between G o and G Y cells from (Table 2 ) the relative increase in aberration yield (with butyrate pre-treatment) is more than by a factor of 1-5 in both the stages; with donors E, F and G (Table 3) however, the increases are smaller (range: l-2-l-3x). It is unlikely that these results reflect different proportions of second division cells in the different series because these proportions are approximately the same (last column of Table 3 ).
(c) Experiments with bleomycin
The results of a pilot study using butyrate (3 mM> pretreated G o lymphocytes, 2 h bleomycin treatment and with a culture time (after PHA simulation) of 46 h (results not given) showed that such pre-treatment also leads to an increase (1-2-1-6-fold) in the yields of dicentrics and rings. With acentrics and chromatid aberrations, striking increases were noted only at the highest concentration of bleomycin. However, in this experiment, the proportions of second division cells were relatively high in some treatment groups.
Consequently additional experiments were done with blood from donors A and B using a fixation time of 44 h. The data are summarized in Table 4 and show that butyrate pre-treatment leads to an enhancement in the frequencies of bleomycin-induced dicentrics and rings (relative increases in the range from l-4x to l-8x); the results with acentrics however show much variation (no enhancement to 2-6-fold enhancement).
(d) Comparison of the effects of X-rays and bleomycin in butyrate-pretreated G o lymphocytes from the same donors
These experiments were carried out to inquire whether any parallelism can be discerned between the responses of X-irradiated or bleomycin-treated G o cells from the same donor to the modifying effects of butyrate pretreatment i.e. whether the X-ray response will be predictive of bleomycin response. In order to examine this, we used blood from two donors, one whose lymphocytes responded with a high relative increase in the yield of chromosomal aberrations and one with a relatively low relative increase, in the ' butyrate + Xray' treatment groups. The data are given in Table 5 .
As can be seen, with donor B, the relative increases are by factors in the range of 1-4-1-6 in the ' butyrate+ Xray' and in the ' butyrate + bleomycin' groups. With donor J on the other hand, these increases are smaller. These data thus lend credence to the view that there exist inter-individual differences with respect to the modifying effects of butyrate.
(e) Experiments with Down syndrome G o lymphocytes
In these experiments which involved butyrate pretreatment and X-irradiation of G o lymphocytes from Down syndrome patients, the hypotheses and expectations were the following: (i) if the enhancement in the frequencies of X-ray-induced chromosomal aberrations in the butyrate-treated G o lymphocytes from normal individuals is essentially a consequence of chromatin structural modification, then, the Down syndrome lymphocytes should also be responsive to this and the relative increase in aberration yield in the latter in the' butyrate + X-ray' group would be similar to that observed with lymphocytes from normal individuals and (ii) if however, there is an additive or synergistic effect of chromatin structural modification and of the postulated enhanced misrepair of chromosome breaks in Down syndrome lymphocytes, then, in the 'butyrate + X-ray' group, the enhancement in aberration yield would be much higher than in normal lymphocytes under the same treatment conditions. The results are given in Table 6 . It is clear that preirradiation treatment of Down syndrome lymphocytes with butyrate leads to an increase (by about 50%) in the frequencies of dicentrics and rings as is the case with lymphocytes from normal individuals. One is tempted to interpret this finding as being consistent with the first expectation outlined in the preceding paragraph but the results of biochemical studies (Meschini et al., in preparation) to be mentioned later, suggest that the situation is more complicated and even the hypotheses tested may not be sound.
The absolute frequencies of these aberrations in the X-ray series (20-7%, 21-5%, 250%, 21%) however, are not strikingly different from those recorded for lymphocytes from normal individuals (16-19%; see Tables 1 and 2 ). In this context, it is worth recalling that in the experiments of Sasaki and Tonomura (1969) in which blood samples from 34 Down patients were used to study the response to radiation (160 rad of gamma rays), overall there was an enhanced radiosensitivity of Down syndrome lymphocytes to the induction of dicentrics and rings; however, the yields of aberrations varied between patients and in some, the frequencies were well within the range recorded for normal individuals. Since lymphocytes from only two Down patients were used in the present work, and the aim was to examine butyrate effects, it does not seem profitable to speculate on the possible reasons for the near-similarity of responses between normal and Down syndrome lymphocytes to the Xray induction of chromosomal damage.
Possible mechanism of butyrate effect on radiationinduced chromosomal aberrations. In our earlier work with G o lymphocytes (Sankaranarayanan et al. 1985) , we tentatively interpreted the cytogenetic results (enhancement of the frequencies of radiation-induced chromosomal aberrations in butyrate-treated groups) ° Includes I tricentric counted as 2 dicentrics.
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Two of these cells were highly abnormal: one contained 4 dicentrics, 3 tricentrics, 3 tetracentrics, 1 pentacentric, 1 ring, 6 acentric fragments (and 3 chromatid breaks and 1 gap); the other abnormal cell contained 26 chromatid breaks and 1 acentric fragment. The aberrations from these cells were excluded from calculations. 
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as a consequence of butyrate-induced conformational change in the chromatin. The basis for this interpretation was two-fold: (i) butyrate is known to induce conformational changes in chromatin and (ii) in our biochemical experiments, the numbers and extent of repair of DNA strand breaks (at 10 Gy; measured using the nucleoid sedimentation technique as described by Mullenders et al. 1983) were the same in butyrate-treated and untreated cells. Experiments with lower doses (unpublished results) also did not provide any consistent evidence for increased frequency of strand breaks in butyrate-pretreated cells. In attempts to quantify induced strand breaks using the alkaline elution technique, again no significant differences were found between the 'X-ray only' and in the 'butyrate-I-X-ray' groups (Meschini et al. under preparation) . The results were also negative when the frequency of strand breaks was measured using the competitive immunoassay employing a monoclonal antibody directed against single-stranded DNA as described by Schans et al. (1989) .
All these results -obtained with different biochemical approaches to study the mechanism of butyrate effect -show that butyrate-induced chromatin modification does not lead to an enhancement of DNA damage in X-irradiated cells: therefore, increased strand breaks cannot be invoked to explain the observed increases in the frequencies of chromosomal aberrations in the 'butyrate + X-ray' groups. Similar conclusions can be drawn from the data published by Smith (1986) .
Further experiments were carried out to examine whether the increased aberration frequencies in the 'butyrate + X-ray' groups could be due to inhibition of strand-break repair by butyrate. Alkaline elution studies as well as premature chromosome condensation studies indicated (data not shown; Mechini et al. under preparation) that there was an impairment of repair of DNA strand breaks: in both types of experiments, the frequency of strand breaks remaining unrepaired was higher at different recovery times in lymphocytes treated with butyrate relative to those which received no butyrate treatment. These results thus suggest that it is the inhibition of repair by butyrate and not differential induction of strand breaks (in the butyrate-treated versus untreated lymphocytes) that is probably responsible for the increased frequencies of chromosomal aberrations in the butyrate pre-treated lymphocytes irradiated with X-rays, relative to those lymphocytes which received X-rays alone.
In conclusion, the results presented in this paper and in the earlier one (Sankaranarayanan et al. 1985) demonstrate that in vitro butyrate pre-treatment of human lymphocytes either in the G o or in the G, stage leads to an enhancement of the frequencies of X-rayinduced chromosomal aberrations; such pre-treatment of G o lymphocytes from Down syndrome individuals also leads to increased yields of chromosomal aberra-tions. There are inter-individual differences in sensitivity to the X-ray induction of chromosomal aberrations in G o and in G 1 lymphocytes, and the responses to butyrate pre-irradiation treatment follow a similar pattern: the higher the relative increase in aberration yield in G o , the higher is such an increase in G x and vice versa.
In G o lymphocytes, butyrate pre-treatment leads to an enhancement of the frequencies of dicentrics and rings induced by the radiomimetic compound, bleomycin. The relative increase in the yield of these aberrations in G o lymphocytes in the ' butyrate+ Xray' group provides a reasonably good indication of the magnitude of enhancement expected with butyrate + bleomycin treatment.
The results of biochemical studies (to be published later) lend credence to the view that butyrate pretreatment inhibits repair of DNA damage in Xirradiated lymphocytes and that this (and not increased strand breaks in the butyrate-treated groups) may be responsible for the increase in aberration yields in X-irradiated lymphocytes pre-treated with butyrate. If this interpretation is correct, it would also mean that the butyrate-induced chromatin conformational changes do not interfere with the factors responsible for the higher yield of chromosomal aberrations recorded in earlier studies with Down syndrome G o lymphocytes exposed to X-irradiation.
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